Results 161 to 170 of about 26,648 (276)
Caenorhabditis elegans as an in vivo model system for human inherited primary arrhythmia syndromes
Abstract figure legend Most genes involved in inherited primary arrhythmia syndromes (IPAS) are conserved in Caenorhabditis elegans, where genetic manipulation enables functional characterization of variants, identification of regulatory proteins, and in vivo drug testing.
Antoine Delinière +6 more
wiley +1 more source
Corrigendum: The impact of Chinese COVID-19 pandemic on the incidence of peripheral facial nerve paralysis after optimizing policies. [PDF]
Yu E +6 more
europepmc +1 more source
Facial nerve paralysis caused by a T-cell lymphoma. [PDF]
Nachtsheim L +4 more
europepmc +1 more source
Post-surgery cholesteatoma complicated by facial nerve paralysis: A case report from Afghanistan. [PDF]
Haghjoo S +5 more
europepmc +1 more source
ABSTRACT Background and Objectives Neuromyelitis optica spectrum disorder (NMOSD) is a chronic disorder with a relapsing–remitting disease course that impacts patients' quality of life. Oral glucocorticoids (OGCs) have been the standard of care for NMOSD in Japan; however, their chronic use is associated with adverse events (AEs).
Yuko Shimizu +7 more
wiley +1 more source
Lower Motor Neuron Facial Nerve Paralysis Following Recombinant Hepatitis B Vaccine Administration: A Case Report and Literature Review. [PDF]
Ghouri RG +5 more
europepmc +1 more source
Facial Nerve Paralysis Due to Spontaneous Intracranial Hypotension. [PDF]
Sajjadi A +5 more
europepmc +1 more source
Facial nerve paralysis as presenting sign of congenital cholesteatoma in an adult
Nevo Margalit +3 more
openalex +1 more source
ABSTRACT Objectives Although satralizumab, an interleukin‐6 receptor inhibitor, effectively prevents relapses in neuromyelitis optica spectrum disorder (NMOSD), infections are reported to be the most common adverse reactions. To support Japanese patients receiving satralizumab, “Circle”—a 1‐year patient support program—was developed.
Kazuo Fujihara +3 more
wiley +1 more source
ABSTRACT Background Because salivary gland cancers (SGC) are rare and include different tumor subtypes, data on their long‐term quality of life and late toxicities are sparse. Methods Multi‐national study including SGC survivors more than 5 years after diagnosis.
Susanne Singer +26 more
wiley +1 more source

